Every earnings call for BAYERCROP — management tone, guidance, KPIs and promise tracking, quarter by quarter.
BAYERCROP · 5 transcripts · Chemicals · latest Q2 FY26EPS (FY25) ₹126 (−24% YoY). H1 FY26 Revenue grew 3% YoY despite a challenging and erratic monsoon season in Q2.
Read full transcript & analysisRevenue CAGR (5-Year) 9%; OpEx CAGR (5-Year) 6.1%; Profit Growth (FY24) 6.2% (+6% YoY). Revenue from operations stayed flat for FY24, while profit increased by 6.2% due to prudent OpEx management.
Read full transcript & analysisROCE 33%. Revenue from operations grew 9% YoY for FY23, with a 4-year CAGR of 12.5% since the Monsanto merger.
Read full transcript & analysisRevenue ₹4,730 cr (+11% YoY); PAT ₹650 cr (+31% YoY); PBT (Pre-Exceptional) ₹790 cr. Q4 Revenue from operations grew 31% YoY to ₹960 crores (9.6 billion INR).
Read full transcript & analysisRevenue (H1) 27.8 billion (+7% YoY); EBITDA Margin (Q2) 16%; Profit After Tax (H1) 5.4 billion (−12% YoY). H1 Revenue grew 7% YoY to ₹27.8 billion, while Q2 Revenue declined 1% to ₹13.6 billion.
Read full transcript & analysis